VZV gE protein, also known as glycoprotein E of varicella-zoster virus, is a research-grade and GMP-grade biological material designed for advanced vaccine and diagnostic development workflows. This protein is highly relevant in herpes zoster vaccine development, especially for recombinant subunit vaccine research, immunogenicity studies, antigen screening, and adjuvant formulation optimization. It is also suitable for differential diagnosis applications where precise VZV antigen recognition is required. As one of the most important envelope glycoproteins of varicella-zoster virus, gE is widely used in laboratory and translational research focused on viral pathogenesis, immune response profiling, and assay development. Its availability in research grade and GMP grade supports both early-stage R&D and more controlled preclinical or process-development applications. For B2B buyers in life sciences, biotech, and vaccine manufacturing, VZV gE protein is a specialized antigen source for building reliable experimental systems and developing next-generation zoster-related biologics and diagnostics.
Key Features
| Features | Description |
|---|---|
| Product Identity | Varicella-zoster virus glycoprotein E (VZV gE protein) |
| Primary Use | Suitable for herpes zoster vaccine development and antigen-based research |
| Research Applications | Used in adjuvant formulation research, immunogenicity studies, and differential diagnosis |
| Quality Level | Available in research grade and GMP grade |
| Target Market | Designed for biotechnology, pharmaceutical, and diagnostic R&D applications |
| Attributes | Description |
|---|---|
| Product Name | VZV gE protein |
| Biological Identity | Glycoprotein E of varicella-zoster virus |
| Application Area | Herpes zoster vaccine development |
| Secondary Applications | Adjuvant formulation research and differential diagnosis |
| Quality Level | Research grade / GMP grade |
| Organism Source | Varicella-zoster virus (VZV) |
| Product Type | Recombinant viral antigen / protein for research use |
| MOQ | 1 |
| Store Name | Swasti Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
VZV gE is a key viral glycoprotein and a major antigen target in herpes zoster vaccine research, making it useful for evaluating immune responses and subunit vaccine performance.
Yes, the VZV gE protein is suitable for adjuvant formulation research where antigen-adjuvant interactions and immune enhancement need to be assessed.
Yes, it can be used in differential diagnosis and assay development where VZV-specific antigen detection is required.
The product is offered in research grade and GMP grade, supporting both exploratory research and more controlled development workflows.
Biotech companies, pharmaceutical R&D teams, vaccine developers, and diagnostic manufacturers commonly source VZV gE protein for specialized research applications.
Inclusive of all taxes
You Save: 0
Vadodara , India
Manufacturer, Trader, Exporter, Importer
GST- 24AIXPB0733C1ZO
Trust Mark
